Smith & Nephew (SNNUF) Liabilities from Discontinued Operations (2011 - 2012)
Smith & Nephew (SNNUF) reported Liabilities from Discontinued Operations of 16000000.0 for Q1 2012, down 15.79% quarter-over-quarter from 19000000.0 in Q4 2011.
Smith & Nephew (SNNUF) Liabilities from Discontinued Operations (2011 - 2012) Analysis & Trends
Smith & Nephew has reported Liabilities from Discontinued Operations for 2 years, with the latest figure at 16000000.0 in Q1 2012.
- For the quarter ending Q1 2012, Liabilities from Discontinued Operations changed N/A year-over-year to 16000000.0; the trailing twelve-month figure through Mar 2012 stood at 16000000.0 (changed N/A YoY), and the FY2011 full-year result was 19000000.0, changed N/A from the prior year.
- Liabilities from Discontinued Operations for Q1 2012 stood at 16000000.0, down from 19000000.0 in the prior quarter.
- The five-year high for Liabilities from Discontinued Operations was 19000000.0 in Q4 2011, with the low at 16000000.0 in Q1 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn |
| 10 | Smith & Nephew | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2012 | 16.00 Mn |
| Mar 31, 2012 | 16.00 Mn |
| Dec 31, 2011 | 19.00 Mn |
| Dec 31, 2011 | 19.00 Mn |